Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Celecoxib MeSH Descriptor Data 2025


MeSH Heading
Celecoxib
Tree Number(s)
D02.065.884.060.020
D02.455.426.559.389.085.020
D02.886.590.700.090.020
D02.886.590.700.247
D03.383.129.539.160
Unique ID
D000068579
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000068579
Scope Note
A pyrazole derivative and selective CYCLOOXYGENASE 2 INHIBITOR that is used to treat symptoms associated with RHEUMATOID ARTHRITIS; OSTEOARTHRITIS and JUVENILE ARTHRITIS, as well as the management of ACUTE PAIN.
Entry Term(s)
4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
Celebrex
SC 58635
SC-58635
Pharm Action
Anti-Inflammatory Agents, Non-Steroidal
Cyclooxygenase 2 Inhibitors
Registry Numbers
JCX84Q7J1L
0
Related Numbers
169590-42-5
Public MeSH Note
2016; CELECOXIB was indexed under PYRAZOLES 1997-2015, and under SULFONAMIDES 1997-2015
History Note
2016 (1997)
Date Established
2016/01/01
Date of Entry
2015/07/01
Revision Date
2023/06/08
Celecoxib Preferred
Celebrex Narrower
SC 58635 Narrower
page delivered in 0.135s